Peterson Renuka, Calamur Nandini, Fiore Andrew, Huddleston Charles, Spence Kimberly
Department of Pediatrics, Saint Louis University School of Medicine, SSM Health Cardinal Glennon Children's Medical Center, 1465 S. Grand Boulevard, Saint Louis, MO, 63104, USA.
Department of Surgery, Saint Louis University School of Medicine, SSM Health Cardinal Glennon Children's Medical Center, Saint Louis, MO, USA.
Pediatr Cardiol. 2018 Jan;39(1):140-147. doi: 10.1007/s00246-017-1738-y. Epub 2017 Sep 25.
Cardiac intervention remains controversial in patients with trisomy 13 and 18 and little is known about factors that may affect outcomes. The goal of this study was to evaluate preoperative factors and surgical approach with respect to outcomes in these patients. Patients with congenital heart disease and trisomy 13 or 18 presenting to our institution from 2004 through 2015 were retrospectively reviewed. Patients were grouped into complete intervention, palliated intervention, and non-intervention. Pre-intervention variables, timing and type of intervention, post-intervention outcomes, and survival were recorded and comparisons were made between the groups. Of 34 patients, 18 cardiac interventions were performed. Complete repair was performed in 11(61%) and palliation in 7(39%). Median age for complete repair was 9.2 vs. 1.7 months in palliated patients (p < 0.001) and palliated patients were smaller (median 2.5 vs. 5.2 kg, p < 0.001). All patients who underwent complete repair survived to discharge compared to only 57% of patients that were palliated (p = 0.04). Palliated patients had longer intubation and time to discharge (p < 0.05). Survival at last follow-up was greater in the complete repair group compared with palliated patients and non-intervention patients (72, 14, and 18%, p = 0.009) with a longer median length of survival in the complete repair group (p = 0.002). In our group of trisomy 13 and 18 patients, those able to undergo complete repair had improved outcomes. Patients undergoing complete repair were older and bigger; this suggests that delaying intervention and optimizing the likelihood of complete repair may be beneficial.
对于13三体和18三体综合征患者,心脏介入治疗仍存在争议,而且对于可能影响治疗结果的因素知之甚少。本研究的目的是评估这些患者术前因素和手术方式对治疗结果的影响。对2004年至2015年期间到我院就诊的患有先天性心脏病且为13三体或18三体综合征的患者进行回顾性研究。患者被分为完全介入组、姑息介入组和非介入组。记录介入前变量、介入时间和类型、介入后结果及生存率,并对各组进行比较。34例患者中,进行了18例心脏介入治疗。11例(61%)进行了完全修复,7例(39%)进行了姑息治疗。完全修复患者的中位年龄为9.2个月,而姑息治疗患者为1.7个月(p<0.001),姑息治疗患者体型更小(中位体重2.5 kg对5.2 kg,p<0.001)。所有接受完全修复的患者均存活至出院,而接受姑息治疗的患者仅57%存活(p=0.04)。姑息治疗患者的插管时间和出院时间更长(p<0.05)。与姑息治疗患者和非介入治疗患者相比,完全修复组在最后一次随访时的生存率更高(分别为72%、14%和18%,p=0.009),完全修复组的中位生存时间更长(p=0.002)。在我们的13三体和18三体综合征患者组中,能够接受完全修复的患者治疗结果更好。接受完全修复的患者年龄更大、体型更大;这表明延迟介入并优化完全修复的可能性可能有益。